stockrow
Friday 6 November 2026
Export CBT’s income statement to Excel — free account
Cabot Corporation
CBT Basic Materials Specialty Chemicals
Cabot Corporation’s revenue for fiscal 2025 (year ended September 2025) was $3.7 billion, down 7.04% from fiscal 2024.
- Revenue
- +12.2%
- EPS
- +79.4%
- Free cash flow
- −51.7%
- Total debt
- +10.8%
Quarter to September 2026, against a year earlier
71.14
1.83
−2.51%
Follow CBT
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
18.37 | 25.51 | 14.18 | 11.53 |
+8 more quarters Free account |
P/S ratio |
1.06 | 1.29 | 1.10 | 0.97 | |
P/FCF ratio |
18.51 | 15.22 | 9.07 | 8.71 | |
P/Operating CF |
27.70 | 62.48 | 50.86 | 27.72 | |
P/B ratio |
2.24 | 2.70 | 2.32 | 2.02 | |
Price to Tangible BV |
2.50 | 3.03 | 2.61 | 2.27 | |
EV/Sales |
1.32 | 1.57 | 1.39 | 1.22 | |
EV/EBITDA |
7.37 | 8.48 | 6.79 | 5.83 | |
EV/Operating CF |
11.78 | 11.49 | 7.40 | 6.58 | |
EV/FCF |
23.17 | 18.54 | 11.49 | 10.95 | |
Quick Ratio |
1.30 | 0.86 | 0.85 | 0.97 | |
Current Ratio |
2.16 | 1.47 | 1.45 | 1.67 | |
Net Debt/EBITDA |
0.00 | 6.91 | 5.88 | 5.27 | |
Debt/Assets |
31.08% | 32.03% | 33.33% | 29.97% | |
Debt/Equity |
0.71 | 0.73 | 0.77 | 0.65 | |
Asset Turnover |
0.95 | 0.93 | 0.93 | 0.98 | |
Operating CF/Net income |
2.17 | 12.50 | 1.15 | 1.73 | |
Capex/Depreciation |
(1.08) | (0.76) | (0.92) | (1.68) | |
Interest Coverage |
5.76 | 5.44 | 7.17 | 7.17 | |
Research and Development Expense of Revenue |
1.39% | 1.32% | 1.55% | 1.53% | |
Selling, General and Administrative Expense of Revenue |
6.84% | 7.43% | 7.41% | 8.13% | |
Intangible Assets out of Total Assets |
0.05 | 0.05 | 0.05 | 0.05 | |
Share Based Compensation of Revenue |
0.00% | 0.61% | 0.44% | 0.35% | |
Graham Net Nets |
(0.13) | (0.12) | (0.17) | (0.16) | |
Graham Number |
56.92 | 51.88 | 62.26 | 65.15 | |
Earnings Yield |
5.44% | 3.92% | 7.05% | 8.68% | |
Free Cash Flow Yield |
5.40% | 6.57% | 11.03% | 11.48% | |
Revenue per Share |
19.59 | 19.03 | 17.38 | 16.11 | |
Operating CF per Share |
2.78 | 1.45 | 1.48 | 2.39 | |
Capex per Share |
(1.07) | (0.74) | (0.87) | (1.31) | |
Free Cash Flow per Share |
1.71 | 0.72 | 0.62 | 1.08 | |
Cash per Share |
4.93 | 4.85 | 4.85 | 4.36 | |
Shareholders Equity per Share |
34.39 | 33.60 | 32.44 | 32.81 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
34.39 | 33.60 | 32.44 | 32.81 | |
Free Cash Flow |
88.00 | 37.00 | 32.00 | 57.00 | |
Working Capital |
937.00 | 530.00 | 479.00 | 583.00 | |
Capital Expenditures |
(55.00) | (38.00) | (45.00) | (69.00) | |
Net Current Asset Value |
(511.00) | (576.00) | (663.00) | (571.00) | |
EV/EBIT |
10.40 | 11.58 | 8.83 | 7.38 | |
Capex to Sales |
0.05 | 0.04 | 0.05 | 0.08 | |
Price to Operating Income |
8.30 | 9.51 | 6.97 | 5.87 | |
| Other line items | |||||
Average Receivables |
736.00 | 710.00 | 698.00 | 646.50 | |
Average Payables |
682.00 | 633.00 | 587.50 | 587.00 | |
Average Inventory |
544.00 | 548.50 | 531.50 | 519.50 | |
Average Assets |
3,921.50 | 3,906.00 | 3,840.50 | 3,699.50 | |
Average Common Equity |
1,738.00 | 1,708.50 | 1,638.50 | 1,622.00 |
Columns are period end dates · fundamentals updated 5 Nov 2026